Frequency of Left Atrial Thrombus Among Patients with Mitral Stenosis Undergoing Percutaneous Trans-Septal Mitral Commissurotomy

Authors

  • Asfandiyar Khan Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan
  • Muhammad Asif Iqbal Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan
  • Usama Fahad Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan
  • Roohulamin Department of Cardiology, Lady Reading Hospital, Peshawar, Pakistan
  • Muhammad Sohail Department of Medicine, Lady Reading Hospital, Peshawar, Pakistan
  • Hassan Ali Department of Cardiology, Bacha Khan Medical Complex, Swabi, Pakistan

DOI:

https://doi.org/10.70749/ijbr.v3i6.1909

Keywords:

Mitral stenosis, Left atrial thrombus, Percutaneous trans septal mitral commissurotomy, Hypertension

Abstract

 Mitral stenosis (MS), most commonly resulting from rheumatic heart disease, predisposes to left atrial thrombus (LAT) formation due to atrial enlargement, stasis of blood flow, and structural remodeling. LAT poses a major risk of systemic embolization and directly influences procedural planning for percutaneous trans-septal mitral commissurotomy (PTMC). This cross-sectional study was carried out in Department of Cardiology, Lady Reading Hospital, Peshawar, between 24 October 2024 and 24 April 2025 to find out the frequency of LAT and related factors in patients under grass root surgery PTMC. Consecutive non-probability sampling was conducted among 133 patients with age 1870 years with symptomatic MS. Baseline demographic and clinical information such as comorbidities, anthropometric measurements, were noted. All the subjects were subjected to prep r o c e d u r a l transesophageal echocardiography to identify LAT. Data analysis was performed with SPSS version 21 with Stratified analysis used to evaluate relationships between LAT and possible effect modifiers. The average age of the cohort was 45.6 11.8 years in total, with the largest proportion of females (62.4%). The occurrence of LAT was found in 13 individuals (9.8%). Prevalence of LAT was significantly correlated to hypertension (p = 0.03) and BMI >25kg/m 2 (p = 0.04) with no significant correlation with either gender, residence, diabetes or smoking history. These findings stress the importance of extensive pre-procedural screening and mention among modifiable risk factors that can lead to thrombus in patients with MS. Clinicians can streamline procedural safety by means of identifying high risk subsets to minimize embolic complications during PTMC. More research is necessary to determine whether the long-term effects of modifying risk factors influence the prevalence and clinical outcome of LAT in the population. 

Downloads

Download data is not yet available.

References

1. Harky A, Botezatu B, Kakar S, Ren M, Shirke MM, Pullan M. Mitral valve diseases: pathophysiology and interventions. Prog Cardiovasc Dis. 2021;67(15):98-104.

https://doi.org/10.1016/j.pcad.2021.03.008

2. Sahin O, Savas G. Relationship between presence of spontaneous echo contrast and platelet‐to‐lymphocyte ratio in patients with mitral stenosis. Echocardiography. 2019;36(5):924-9.

https://doi.org/10.1111/echo.14338

3. Tek M, Efe FK. The association between platelet to lymphocyte ratio and left atrial appendage thrombogenic milieu in patients with non-valvular atrial fibrillation. Ankara Med J. 2022;22(2):260-9.

https://doi.org/10.5505/amj.2022.89896

4. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet. 2009;373(9658):155-66.

https://doi.org/10.1016/s0140-6736(09)60040-4

5. Velangi PS, Choo C, Chen KH, Kazmirczak F, Nijjar PS, Farzaneh-Far A, et al. Longterm embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study. Circulation. Cardiovasc Imaging. 2019;12(11):e009723.

https://doi.org/10.1161/circimaging.119.009723

6. Gholoobi A, Poorzand H. Multiple coronary fistula formation associated with a huge left atrial thrombus in rheumatic mitral valve stenosis. J Cardiol Cases. 2014;9(3):124-6.

https://doi.org/10.1016/j.jccase.2013.11.008

7. Rmilah AA, Tahboub MA, Alkurashi AK, Jaber SA, Yagmour AH, Al-Souri D, et al. Efficacy and safety of percutaneous mitral balloon valvotomy in patients with mitral stenosis: A systematic review and meta-analysis. Heart Vascul. 2021;33(23):1007-15.

https://doi.org/10.1016/j.ijcha.2021.100765

8. Turi ZG. The 40th anniversary of percutaneous balloon valvuloplasty for mitral stenosis: current status. Heart. 2022;6(5):45-9.

https://doi.org/10.1016/j.shj.2022.100087

9. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's heart disease e-book: A textbook of cardiovascular medicine. Health Sci. 2011;7(5):35-42.

https://doi.org/10.1016/b978-1-4377-0398-6.00124-4

10. Galusko V, Ionescu A, Edwards A, Sekar B, Wong K, Patel K, et al. Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations. Eur Heart J. 2022;8(6):602-18.

https://doi.org/10.1093/ehjqcco/qcab083

11. Eng MH, Kargoli F, Wang DD, Frisoli TM, Lee JC, Villablanca PS, et al. Short‐and midterm outcomes in percutaneous mitral valve replacement using balloon expandable valves. atheter Cardiovasc Interv. 2021;98(6):1193-203.

https://doi.org/10.1002/ccd.29783

12. Gill BU, Abbas T, Haq RU, Qureshi BA, Hashmi KA, Ahmed I, et al. Frequency of left atrial thrombus in patients of mitral stenosis suitable for percutaneous trans-septal mitral commissurotomy. Pak Heart J. 2015;48(1):48-51.

Downloads

Published

2025-07-08

How to Cite

Khan, A., Iqbal, M. A., Fahad, U., Roohulamin, Sohail, M., & Ali, H. (2025). Frequency of Left Atrial Thrombus Among Patients with Mitral Stenosis Undergoing Percutaneous Trans-Septal Mitral Commissurotomy. Indus Journal of Bioscience Research, 3(6), 855-858. https://doi.org/10.70749/ijbr.v3i6.1909